Illinois Administrative Code (Last Updated: March 27, 2024) |
TITLE77. PUBLIC HEALTH |
PART2085. RESEARCH |
§ 2085.10. Definitions |
§ 2085.15. Eligibility |
§ 2085.20. Authorization Procedure |
§ 2085.25. Terms and Conditions of Authorization |
§ 2085.30. Informed Consent |
§ 2085.35. Research Order Blanks for Dispensing Delta-9-THC Capsules |
§ 2085.40. Labeling Requirements |
§ 2085.45. Packaging Requirements |
§ 2085.50. Confidentiality of Cancer Chemotherapy Patients Receiving delta-9-THC Medication |
§ 2085.55. Reports and Recordkeeping |
§ 2085.60. Audits and Inspections |
§ 2085.65. Security |
§ 2085.EXHIBIT A. DASA Form 229-1 |
§ 2085.EXHIBIT B. DASA Form 229-2 |
§ 2085.EXHIBIT C. Special Instructions Covering Research Medication Order Forms for Delta-9-Tetrahydrocannabinol |
§ 2085.EXHIBIT D. Special Instructions Covering Research Medication Labels for Delta-9-Tetrahydrocannabinol Containers |
§ 2085.EXHIBIT E. Research Order for Delta-9-Tetrahydrocannabinol |
SOURCE: Adopted at 5 Ill. Reg. 4868, effective April 22, 1981; transferred July 1, 1984 to the Department of Alcoholism and Substance Abuse by the Alcoholism and substance Abuse Act; codified at 8 Ill. Reg. 19340; recodified from Department of Alcoholism and Substance Abuse to Department of Human Services at 21 Ill. Reg. 9319.
|
Notation
AUTHORITY: Implementing and authorized by Section 11 of the Cannabis Control Act [720 ILCS 550/11].